查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404819

基於透明質酸鈉的產品市場規模、佔有率和趨勢分析報告：按類型、應用{藥品、化妝品}、地區和細分市場預測，2023-2030

Sodium Hyaluronate-based Products Market Size, Share & Trends Analysis Report By Type (Injectable, Topical), By Application {Pharmaceuticals (Orthopedic, Ophthalmology, Urology), Cosmetics}, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

透明質酸鈉產品市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球透明質酸鈉產品市場規模將達到177.3億美元，2023年至2030年複合年成長率為7.7%。

促進市場成長的因素包括老年人口的增加、骨關節炎和白內障的高盛行率、技術進步、意識的提高以及世界上非侵入性美容手術數量的增加。

主要由於世界高齡化人口的增加，抗老化化妝品和逆轉衰老徵兆的美容護理的需求不斷增加。透明質酸鈉（NaHA）比透明質酸更易溶解，分子更小，對皮膚的滲透性更好。它擴大用於真皮填充劑，將其註入皮膚區域以填充皺紋並恢復更年輕的外觀。市面上銷售的 FDA 批准的透明質酸鈉皮膚填充劑包括 Restylane Defyne、Refyne 和 Restylane。因此，在預測期內，對此類產品的需求預計將成為透明質酸鈉產品的強大推動因素。

世界衛生組織預測，到2050年，全球60歲以上人口中估計有15%將患有有症狀的骨關節炎。隨著高齡化，肥胖和久坐生活方式等其他危險因子的增加預計將進一步加劇這一問題。由於上述因素以及透明質酸鈉產品在治療這些疾病方面的有效性，預計其市場在預測期內將顯著成長。

儘管基於透明質酸鈉的產品具有顯著的優點，但其昂貴的特性可能使某些病患小組無法承受。例如，美國NaHA 注射劑的平均價格為 350 美元至 800 美元。此外，從透明質酸鈉真皮填充劑獲得的益處是暫時的，永續長達 18 個月，並且可能需要額外的維持治療來維持所需的效果，從而導致額外的成本。單相和雙相透明質酸產品是昂貴的產品，並非適合所有患者。其高價格主要體現在製造成本高。

此外，SARS-CoV-2的爆發對透明質酸鈉市場產生了重大影響。全球外科手術數量的減少和供應鏈中斷減少了全球對透明質酸鈉產品的需求。

主要企業正在利用新產品發布和策略合作夥伴關係等多種策略來擴大產品系列併提高競爭力。例如，2020年，工業與Eisai在韓國建立了SI-613（雙氯芬酸鈉酸共軛透明質酸鈉）的銷售合作關係。根據該協議，Eisai韓國公司將成為 SI-613 在韓國的獨家經銷商。

透明質酸鈉產品市場報告亮點

  • 到2022年，注射劑領域將佔據90%以上的市場佔有率，因為它具有廣泛的用途，包括用於整容手術的真皮填充劑、用於骨關節炎的止痛劑、用於白內障摘除的手術輔助劑以及用於婦科的防沾黏劑手術。佔銷售額的最大佔有率。
  • 2022 年，製藥業佔最大收益佔有率，超過 60%，由於各種製藥應用的高使用率，預計在預測期內將以 7.9% 的最快複合年成長率成長。
  • 北美地區主導市場，2022 年收益佔有率最大，超過 35%。這是由於與其他地區相比，醫療保健支出更高，白內障和皮膚填充劑手術的數量也更多。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章微針給藥系統市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 透明質酸鈉產品市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章 透明質酸鈉產品：類型估計與趨勢分析

  • 透明質酸鈉產品市場：重點
  • 透明質酸鈉產品市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 局部的
    • 2018-2030 年局部市場估計與預測
  • 可注射的
    • 2018-2030 年注射藥品市場估計與預測
  • 其他
    • 2018-2030 年其他市場估計與預測

第5章 透明質酸鈉產品：估計使用量與趨勢分析

  • 透明質酸鈉產品市場：重點
  • 透明質酸鈉產品市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 藥品
    • 2018-2030 年醫藥市場估計與預測
  • 化妝品
    • 2018-2030 年化妝品市場預測

第6章 透明質酸鈉產品：區域估計與趨勢分析

  • 區域展望
  • 基於透明質酸鈉的產品：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Allergan, Inc.(a part of AbbVie, Inc.)
    • Galderma SA
    • Bohus BioTech AB
    • LG Chem Ltd.
    • Syner-Med (Pharmaceutical Products) Ltd.
    • Anika Therpeutics Inc.
    • Cadila Pharmaceuticals Ltd.
    • Ferring Pharmaceuticals BV
    • Fidia Farmaceutici SpA
Product Code: GVR-4-68038-345-4

Sodium Hyaluronate-based Products Market Growth & Trends:

The global sodium hyaluronate-based products market size is expected to reach USD 17.73 billion by 2030, registering a CAGR of 7.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributed to factors such as the increasing geriatric population, a high prevalence of osteoarthritis and cataracts, technological advancements, rising awareness, and a growing number of non-invasive aesthetic procedures globally.

The demand for antiaging cosmetics and aesthetic treatments, which help people in reversing their aging signs, is increasing, mainly due to a global increase in the aging population. Sodium hyaluronate (NaHA) is more soluble than hyaluronic acid, along with having smaller molecules and greater skin penetration. It is increasingly being used in dermal fillers that are injected into areas of the skin to fill out wrinkles and help restore a more youthful appearance. Some of the FDA-approved sodium hyaluronate dermal fillers available in the market are Restylane Defyne, Refyne, and Restylane. Thus, it is anticipated that the need for such products will act as a high-impact rendering driver for sodium hyaluronate-based products over the forecast period.

The WHO predicts that by 2050, an estimated 15% of the world's population above the age of 60 years will suffer from symptomatic osteoarthritis. Along with the aging population, an increase in other risk factors such as obesity and a sedentary lifestyle is expected to further exacerbate the problem. Due to the aforementioned factors and the effectiveness of sodium hyaluronate products in treating these conditions, its market is expected to grow significantly over the forecast period.

Although sodium hyaluronate-based products offer major benefits, due to their expensive nature, they can be out of reach for certain patient groups. For instance, the average price of NaHA injections in the U.S. ranges from USD 350 to USD 800. Moreover, benefits derived from sodium hyaluronate dermal fillers are temporary, lasting up to 18 months and requiring further upkeep treatments to maintain the desired effect, leading to additional expenses. Single-phase products and duplex products of hyaluronic acid are premium-priced products, and thus, they are not accessible to all patients. Their high price primarily reflects high manufacturing costs.

Moreover, the SARS-CoV-2 pandemic has substantially impacted the sodium hyaluronate market. A decrease in the number of surgical procedures worldwide and disruptions in the supply chain have reduced the demand for sodium hyaluronate-based products worldwide.

Key players are leveraging multiple strategies such as new product launches and strategic partnerships to expand their product portfolio, and thereby, have a more competitive range of offerings. For instance, in 2020, Seikagaku Corporation and Eisai Co., Ltd. formed a marketing alliance for SI-613 (diclofenac-conjugated sodium hyaluronate) in South Korea. Based on this agreement, Eisai Korea, Inc. will be the exclusive distributor of SI-613 in South Korea.

Sodium Hyaluronate-based Products Market Report Highlights:

  • The injectable segment accounted for the largest revenue share of over 90% in 2022 owing to a wide range of applications, such as dermal fillers in cosmetic procedures, pain relief in osteoarthritis, surgical aids in cataract extractions, and anti-adhesives in gynecological operations
  • The pharmaceutical segment held the largest revenue share of over 60% in 2022 and is anticipated to grow at the fastest CAGR of 7.9% over the forecast period owing to the high usage in a variety of pharmaceutical applications
  • North America dominated the market and accounted for the largest revenue share of over 35% in 2022 due to the higher healthcare expenditure and a greater number of cataract and dermal filler procedures as compared to other regions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Microneedle Drug Delivery Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Sodium Hyaluronate - Based Products Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Sodium Hyaluronate-Based Products: Type Estimates & Trend Analysis

  • 4.1. Sodium Hyaluronate-Based Products Market: Key Takeaways
  • 4.2. Sodium Hyaluronate-Based Products Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Topical
    • 4.3.1. Topical market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.4. Injectable
    • 4.4.1. Injectable market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Sodium Hyaluronate-Based Products: Applications Estimates & Trend Analysis

  • 5.1. Sodium Hyaluronate-Based Products Market: Key Takeaways
  • 5.2. Sodium Hyaluronate-Based Products Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Pharmaceuticals
    • 5.3.1. Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.1. Ophthalmic
      • 5.3.1.1.1. Ophthalmic market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.2. Orthopedic
      • 5.3.1.2.1. Ophthalmic market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.3. Urology
      • 5.3.1.3.1. Urology market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.4. Others
      • 5.3.1.4.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4. Cosmetics
    • 5.4.1. Cosmetics market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Sodium Hyaluronate-Based Products: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Sodium Hyaluronate-Based Products: Key Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Allergan, Inc.(a part of AbbVie, Inc.)
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Galderma S.A.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Bohus BioTech AB
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. LG Chem Ltd.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Syner-Med (Pharmaceutical Products) Ltd.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Anika Therpeutics Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Cadila Pharmaceuticals Ltd.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Ferring Pharmaceuticals B.V.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Fidia Farmaceutici S.p.A.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 5 U.S. sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 6 Canada sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 7 Canada sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 8 Europe sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 9 Europe sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 11 Germany sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 12 Germany sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 13 UK sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 14 UK sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 15 France sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 16 France sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 17 Italy sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 18 Italy sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 19 Spain sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 20 Spain sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 21 Sweden sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 22 Sweden sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 23 Norway sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 24 Norway sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 25 Denmark sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 26 Denmark sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 27 Asia Pacific sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 30 China sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 31 China sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 32 Japan sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 33 Japan sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 34 India sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 35 India sodium hyaluronate-based products market, by application, (USD Million) 2018 - 2030
  • Table 36 Australia sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 37 Australia sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 38 Thailand sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 39 Thailand sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 40 South Korea sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 41 South Korea sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 42 Latin America sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 43 Latin America sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 44 Latin America sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 45 Brazil sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 46 Brazil sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 47 Mexico sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 48 Mexico sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 49 Argentina sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 50 Argentina sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 51 Middle East and Africa sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 54 South Africa sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 55 South Africa sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 58 UAE sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 59 UAE sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 60 Kuwait sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 61 Kuwait sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Microneedle drug delivery systems: Market outlook
  • Fig. 9 Microneedle drug delivery systems: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Sodium hyaluronate-based products market driver impact
  • Fig. 15 Sodium hyaluronate-based products market restraint impact
  • Fig. 16 Sodium hyaluronate-based products market strategic initiatives analysis
  • Fig. 17 Sodium hyaluronate-based products market: Type movement analysis
  • Fig. 18 Sodium hyaluronate-based products market: Type outlook and key takeaways
  • Fig. 19 Topical market estimates and forecasts, 2018 - 2030
  • Fig. 20 Injectable market estimates and forecasts, 2018 - 2030
  • Fig. 21 Others market estimates and forecasts, 2018 - 2030
  • Fig. 22 Sodium hyaluronate-based products market: Application movement analysis
  • Fig. 23 Sodium hyaluronate-based products market: Application outlook and key takeaways
  • Fig. 24 Pharmaceutical market estimates and forecasts, 2018 - 2030
  • Fig. 25 Cosmetics market estimates and forecasts, 2018 - 2030
  • Fig. 26 Global sodium hyaluronate-based products market: Regional movement analysis
  • Fig. 27 Global sodium hyaluronate-based products market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 31 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 34 France market estimates and forecasts, 2018 - 2030
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 42 China market estimates and forecasts, 2018 - 2030
  • Fig. 43 India market estimates and forecasts, 2018 - 2030
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030